[Home Respiratory Therapies: SEPAR Technical Document for Institutional Decision Support]. [PDF]
Marcos PJ +4 more
europepmc +1 more source
Predictive performance of fetal growth restriction criteria for adverse perinatal outcomes in a hospital in Popayán, Colombia [PDF]
Gutiérrez-Montufar OO +5 more
europepmc +1 more source
[Ventricular pressure-volume loop and other heart-function metrics can elucidate etiology of failure of TAVI and interventions]. [PDF]
Keshavarz-Motamed Z.
europepmc +1 more source
[Effectiveness of tertiary prevention on quality of life and control of risk factors in patients with ischemic coronary heart disease]. [PDF]
Fernández Coronado R, Olórtegui Yzu A.
europepmc +1 more source
[HEARTS quality: a policy framework to strengthen hypertension and cardiovascular risk management in primary healthcare - insights from HEARTS in the AmericasQualidade da iniciativa HEARTS: marco de políticas para fortalecer o manejo da hipertensão e do risco cardiovascular na atenção primária à saúde. Perspectivas da iniciativa HEARTS nas Américas]. [PDF]
Londoño E +21 more
europepmc +1 more source
Arrhythmic mitral valve complex: diagnostic and therapeutic approach. [PDF]
Trujillo-Flores D +3 more
europepmc +1 more source
[Early orthodontic/orthopedic treatment in patients with class II sagittal anomalies. A review]. [PDF]
Yánez-Zurita C +2 more
europepmc +1 more source
Methodologies for population surveys on violence in rural areas: a scoping review. [PDF]
Bervig CLB +5 more
europepmc +1 more source
Estudio de PharmaMar, SA y Oryzon Genomics SA a través de sus estados de flujos de efectivo
With the aim of carrying out an analysis of the solvency and liquidity of a company through the study of its annual accounts (hereinafter, CCAA), it has been decided to analyze the companies PharmaMar, S.A and Oryzon Genomics, S.A. Both companies, due to the performance of their main activity, are included in the pharmaceutical and biotechnology ...
openaire +1 more source
[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach]. [PDF]
Gómez-Lara J.
europepmc +1 more source

